AAP
AIMT

Arax Advisory Partners’s Aimmune Therapeutics AIMT Stock Holding History

Arax Advisory Partners’s Portfolio AIMT Stock Details AIMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-800
Closed -$13K – 725
2020
Q2 		$13K Hold
800
– – ﹤0.01% 514
2020
Q1 		$12K Hold
800
– – ﹤0.01% 514
2019
Q4 		$27K Hold
800
– – 0.01% 396
2019
Q3 		$17K Hold
800
– – 0.01% 423
2019
Q2 		$17K Buy
+800
New +$16.5K 0.01% 428
2018
Q4 		$19K Hold
800
– – 0.01% 380
2018
Q3 		$22K Buy
+800
New +$22.6K 0.01% 395

Other funds holding AIMT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $14.1B AUM 58.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.83B AUM 190.64% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
WIC
Water Island Capital New York $750M AUM 107.59% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return